Skip to content

At OBOS: Growing Objections to Makena Price Hike

March 30, 2011

Over at Our Bodies Our Blog, I have a post on the FDA’s approval of Makena (17-Hydroxyprogesterone or 17OHP) for prevention of preterm birth and the huge price hike that followed, with links to commentaries on the controversy, including calls for boycotts, questions about the March of Dimes’s role in supporting the approval, lots of good posts from The Preemie Primer blog, and a New England Journal of Medicine perspective piece decrying the potential impact on Medicaid and decrease in access to the drug as a result of the price hike.

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: